# Addition of lactoferrin increases efficacy of three Kayviruses and limits the inflammatory response in pulmonary epithelial cells

**Authors:** Katarzyna Kosznik-Kwaśnicka, Grzegorz Stasiłojć, Milena Grzenkowicz, Małgorzata Stasiłojć, Agnieszka Necel, Lidia Piechowicz

PMC · DOI: 10.1007/s00253-025-13695-9 · Applied Microbiology and Biotechnology · 2026-01-10

## TL;DR

Combining lactoferrin with Kayviruses improves treatment of MRSA pneumonia by reducing bacteria and inflammation in lung cells.

## Contribution

This study shows that lactoferrin enhances phage efficacy and reduces inflammation in MRSA-infected cells.

## Key findings

- Phage-lactoferrin combinations significantly reduced MRSA viability in infected cells.
- The treatment protected human cells from cytotoxic effects of bacterial infection.
- The combination limited inflammasome activation and inflammatory response.

## Abstract

Staphylococcus aureus is a major cause of hospital-acquired pneumonia, with methicillin-resistant strains contributing significantly to prolonged illness and mortality. Methicillin-resistant strains can be responsible for up to 75% of infections in certain countries. Therefore, the problem is described as severe, and the search for alternative methods of treatment of such infections is currently one of the priorities in healthcare. Bacteriophages, although historically underutilized, are re-gaining interest for their potential in treating bacterial infections. However, they do have their limitations such as specific ranges of activity and resistance development. Combining phages with antimicrobial agents such as lactoferrin—a natural protein with antimicrobial and anti-biofilm properties—may improve treatment outcomes. In this study, we evaluated the efficacy of three Kayviruses paired with lactoferrin against MRSA in infected pulmonary epithelial cell cultures. The combination significantly reduced bacterial viability, protected human cells from cytotoxic effects of bacterial infection, and decreased inflammasome activation. These findings suggest that phage-lactoferrin combinations may offer a promising, safer alternative for managing MRSA-related pneumonia and reducing dependence on traditional antibiotics.

•Phage lactoferrin mixture had no influence on A549 cells

•Lactoferrin increased phage efficacy and reduced influence of bacteria on cells

•Phage + Lf mixture limited inflammatory response similarly to phages and Lf alone

## Linked entities

- **Proteins:** tf.S (transferrin S homeolog)
- **Diseases:** pneumonia (MONDO:0005249), MRSA (MONDO:0100073)
- **Species:** Staphylococcus aureus (taxon 1280), Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** cytotoxic (MESH:D064420), inflammatory (MESH:D007249), bacterial infection (MESH:D001424), infections (MESH:D007239), pneumonia (MESH:D011014)
- **Chemicals:** Methicillin (MESH:D008712)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12791070/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12791070/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12791070/full.md

---
Source: https://tomesphere.com/paper/PMC12791070